| Product Code: ETC11227183 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of type 2 diabetes drugs and devices to Israel in 2024 were mainly sourced from Switzerland, UK, Belgium, USA, and Germany. Despite the low concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the market saw a slight decline with a negative Compound Annual Growth Rate (CAGR) of -2.14% from 2020 to 2024. The growth rate for the year 2024 also experienced a marginal decrease of -0.41% compared to the previous year. This data suggests a relatively stable market with consistent import sources, albeit with a slight downward trend in recent years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Type 2 Diabetes Drugs and Devices Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 Israel Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Israel Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of type 2 diabetes in Israel |
4.2.2 Increasing awareness about diabetes management and treatment options |
4.2.3 Technological advancements in diabetes drugs and devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diabetes drugs and devices |
4.3.2 High cost associated with diabetes treatment |
4.3.3 Limited reimbursement policies for diabetes medications |
5 Israel Type 2 Diabetes Drugs and Devices Market Trends |
6 Israel Type 2 Diabetes Drugs and Devices Market, By Types |
6.1 Israel Type 2 Diabetes Drugs and Devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Oral Drugs, 2022 - 2032F |
6.1.4 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Injectables, 2022 - 2032F |
6.1.5 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Therapy, 2022 - 2032F |
6.1.6 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.2 Israel Type 2 Diabetes Drugs and Devices Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.2.3 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By SGLT2 Inhibitors, 2022 - 2032F |
6.2.4 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By GLP-1 Agonists, 2022 - 2032F |
6.2.5 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By DPP-4 Inhibitors, 2022 - 2032F |
6.3 Israel Type 2 Diabetes Drugs and Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Glucose Monitors, 2022 - 2032F |
6.3.3 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.3.4 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By CGMs, 2022 - 2032F |
6.3.5 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Smart Insulin Pens, 2022 - 2032F |
6.4 Israel Type 2 Diabetes Drugs and Devices Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.4.5 Israel Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Home Care, 2022 - 2032F |
7 Israel Type 2 Diabetes Drugs and Devices Market Import-Export Trade Statistics |
7.1 Israel Type 2 Diabetes Drugs and Devices Market Export to Major Countries |
7.2 Israel Type 2 Diabetes Drugs and Devices Market Imports from Major Countries |
8 Israel Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
8.1 Percentage of population diagnosed with type 2 diabetes |
8.2 Adoption rate of innovative diabetes drugs and devices |
8.3 Number of clinical trials for diabetes treatment conducted in Israel |
9 Israel Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
9.1 Israel Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Israel Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Israel Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Israel Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
10.1 Israel Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 Israel Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here